| Novel drug-like somatostatin receptor 4 agonists are potential analgesics for neuropathic pain B Kántás, R Börzsei, É Szőke, P Bánhegyi, Á Horváth, Á Hunyady, ... International journal of molecular sciences 20 (24), 6245, 2019 | 35 | 2019 |
| Analgesic effects of lipid raft disruption by sphingomyelinase and myriocin via transient receptor potential vanilloid 1 and transient receptor potential ankyrin 1 ion channel … Á Horváth, M Payrits, A Steib, B Kántás, T Biró-Süt, J Erostyák, G Makkai, ... Frontiers in Pharmacology 11, 593319, 2021 | 11 | 2021 |
| Antinociceptive effects of lipid raft disruptors, a novel carboxamido-steroid and methyl β-cyclodextrin, in mice by inhibiting transient receptor potential vanilloid 1 and … Á Horváth, T Biró-Sütő, B Kántás, M Payrits, R Skoda-Földes, ... Frontiers in Physiology 11, 559109, 2020 | 11 | 2020 |
| In Silico, In Vitro and In Vivo Pharmacodynamic Characterization of Novel Analgesic Drug Candidate Somatostatin SST4 Receptor Agonists B Kántás, É Szőke, R Börzsei, P Bánhegyi, J Asghar, L Hudhud, A Steib, ... Frontiers in Pharmacology 11, 601887, 2021 | 9 | 2021 |
| The heptapeptide somatostatin analogue TT-232 exerts analgesic and anti-inflammatory actions via SST4 receptor activation: In silico, in vitro and in vivo evidence in mice R Börzsei, É Borbély, B Kántás, L Hudhud, Á Horváth, É Szőke, C Hetényi, ... Biochemical Pharmacology 209, 115419, 2023 | 2 | 2023 |
| The Epigenetics of Neuropathic Pain: A Systematic Update G Pethő, B Kántás, Á Horváth, E Pintér International Journal of Molecular Sciences 24 (24), 17143, 2023 | 1 | 2023 |
| Anti-Nociceptive Effects of Sphingomyelinase and Methyl-Beta-Cyclodextrin in the Icilin-Induced Mouse Pain Model Á Horváth, A Steib, A Nehr-Majoros, B Kántás, Á Király, M Racskó, BI Tóth, ... International Journal of Molecular Sciences 25 (9), 4637, 2024 | | 2024 |
| Characterization of novel somatostatin 4 receptor agonists in different pain models B Kántás, Z Helyes, É Borbély | | |
